A number of investment brokers have recently updated their price targets on shares of AtriCure, Inc. (ATRC). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

03/29/2016 – Northland Securities began new coverage on AtriCure, Inc. giving the company a “outperform” rating. They now have a USD 24 price target on the stock.

03/14/2016 – AtriCure, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 23 price target on the stock.

02/24/2016 – AtriCure, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 22 price target on the stock.

02/18/2016 – AtriCure, Inc. had its “sell” rating reiterated by analysts at UBS. They now have a USD 17 price target on the stock.

11/10/2015 – AtriCure, Inc. had its “buy” rating reiterated by analysts at BTIG Research. They now have a USD 30 price target on the stock.

10/29/2015 – AtriCure, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 28 price target on the stock.

10/06/2015 – AtriCure, Inc. had its “buy” rating reiterated by analysts at Leerink Swann.

07/29/2015 – AtriCure, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 26 price target on the stock.

07/28/2015 – AtriCure, Inc. had its “buy” rating reiterated by analysts at Dougherty & Co. They now have a USD 30 price target on the stock.

03/02/2015 – AtriCure, Inc. was downgraded to “underperform” by analysts at Zacks. They now have a USD 16.8 price target on the stock.

02/28/2014 – AtriCure, Inc. had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 33 price target on the stock.

The share price of AtriCure, Inc. (ATRC) was down -3.19% during the last day of trading, with a day high of 14.45. 286642 shares were traded during the last session.

The stock’s 50 day moving average is 16.25 and its 200 day moving average is 18.55. The stock’s market capitalization is 427.65M. AtriCure, Inc. has a 52-week low of 13.65 and a 52-week high of 28.15.

View other investors thoughts on AtriCure, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.